Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 332 followers

Latest posts

Last updated about 10 hours ago

Timetable: Safety referral (Article-20 and Article-31 pharmacovigilance)

about 11 hours ago

Timetable: Safety referral (Article-20 and Article-31 pharmacovigilance)

Timetable: Safety referral (Article 107i, urgent Union procedure)

about 11 hours ago

Timetable: Safety referral (Article 107i, urgent Union procedure)

Timetable: Non-safety referrals

about 11 hours ago

Timetable: Non-safety referrals

Human medicines European public assessment report (EPAR): Tegsedi, inotersen, Date of authorisation: 06/07/2018, Revision: 16, Status: Authorised

about 13 hours ago

Human medicines European public assessment report (EPAR): Tegsedi, inotersen, Date of authorisation...

Human medicines European public assessment report (EPAR): Nugalviq, govorestat, Status: Application withdrawn

about 13 hours ago

Human medicines European public assessment report (EPAR): Nugalviq, govorestat, Status: Application withdrawn

Orphan designation: daratumumab Treatment of plasma-cell myeloma, 17/07/2013 Expired

about 13 hours ago

Orphan designation: daratumumab Treatment of plasma-cell myeloma, 17/07/2013 Expired

EMA/PE/0000232781

about 14 hours ago

EMA/PE/0000232781

EMA/PE/0000232771

about 14 hours ago

EMA/PE/0000232771

EMA/PE/0000232769

about 14 hours ago

EMA/PE/0000232769

EMA/PE/0000232764

about 14 hours ago

EMA/PE/0000232764

EMA/PE/0000232763

about 15 hours ago

EMA/PE/0000232763

EMA/PE/0000232638

about 15 hours ago

EMA/PE/0000232638